英文誌(2004-)
Original Article(原著)
(0284 - 0290)
カラードプラ法による肝腫瘤の鑑別診断 ―腫瘤中心部血流シグナル検出率の検討―
Differential Diagnosis of Liver Tumors Using Color Doppler Flow Imaging: Detectability of Intratumoral Central Color Flow Signal
杤尾 人司1, 冨田 周介2, 岡部 純弘2, 工藤 正俊2, 樫田 博史2, 簑輪 和士1, 島田 啓子1, 濵田 充生1, 三村 純2, 濵田 一美1, 平佐 昌弘2, 伊吹 康良2, 小森 英司2, 織野 彬雄2, 森本 義人1, 藤堂 彰男2
Hitoshi TOCHIO1, Syusuke TOMITA2, Yoshihiro OKABE2, Masatoshi KUDO2, Hiroshi KASHIDA2, Kazushi MINOWA1, Keiko SHIMADA1, Michio HAMADA1, Jun MIMURA2, Kazumi HAMADA1, Masahiro HIRASA2, Yasuyoshi IBUKI2, Hideshi KOMORI2, Akio ORINO2, Yoshito MORIMOTO1, Akio TODO2
1神戸市立中央市民病院臨床病理科腹部超音波室, 2神戸市立中央市民病院消化器センター内科
1Section of Abdominal Ultrasound, Kobe City General Hospital, 2Division of Gastroenterology, Kobe City General Hospital
キーワード : Hepatic tumor, Color Doppler flow imaging, Central color flow signal
In this study, we evaluated the usefulnes of color Doppler flow imaging in the differential diagnosis of various hepatic tumors. Color Doppler flow imaging was performed in 250 patients representing 284 cases of hepatic nodules; 184 cases of hepatocellular carcinoma(HCC), 44 cases of metastatic liver cancer(MLC), and 56 cases of hemangioma. The detectability rates of the intratumoral color flow signal in HCCs, MLCs, and hemangiomas were 57%(105/184), 50%(22/44), and 27%(15/56), respectively. The detectability rates of intratumoral color flow signal in HCCs and in MLCs were significantly higher than the rate in hemaniomas. The detectability rates of “central color flow signal” in HCCs, MLCs, and hemangiomas were 55%(58/105), 39%(9/23), and 20%(3/15) respectively. When the tumor measured less than 5 cm, the detectability rates of “central color flow signal” in HCCs, MLCs, and hemangiomas were 51%(37/73), 21%(3/14), and 18%(2/15), respectively. The detectability of “central color flow signal” in HCCs was significantly higher than that in MLCs or in hemangiomas. We therefore concluded that evaluation of “cental color flow signal” by color Doppler flow imaging was a very useful noninvasive differential diagnosis technique for identifying HCCs, MLCs and hemangiomas.